Found 138 matching trials
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia PHASE3 This Phase 3 study in adult participants with newly diagnosed low-risk APL ...
Show More Learn More & Join Trial
A Study of ATRA in the Treatment of ITP PHASE2 An open-label, multicenter study to compare the efficacy and safety of ATRA...
Show More Location
Peking University Institute of Hematology
Learn More & Join Trial
Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) PHASE1 The goal of this clinical research study is to learn if vorinostat when giv...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia PHASE2 AML of the older patient constitutes a major unmet clinical need since the ...
Show More Location
Klinikum der Technischen Universität Aachen
Learn More & Join Trial
Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety. PHASE1 Investigating the role of 13cis retinoic acid in the treatment of COVID-19 ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP) PHASE1 The objective of the phase I part of the trial is the determination of the ...
Show More Location
Universitätsklinikum Heidelberg
Learn More & Join Trial
Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation PHASE3 This is a randomized, Phase-III, two-arm, open-label, multi-center study in...
Show More Location
Ubbo-Emmius Klinik Aurich
Learn More & Join Trial
Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) PHASE2 To conduct feasibility studies on the use of retinoids in the treatment of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML PHASE2 Diagnosis: Acute myeloid leukemia refractory to intensive induction chemoth...
Show More Location
University Hospital Regensburg
Learn More & Join Trial
Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02) PHASE1 Substudy 02C is part of a larger research study that is testing experimenta...
Show More Location
The Angeles Clinic and Research Institute ( Site 3009)
Learn More & Join Trial